Carlos Quintanilla‐Bordás

Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study

Carmen Alcalá, Carlos Quintanilla‐Bordás, Francisco Gascón et al. · Journal of Neurology · 2022 · 24 citations · Full text

Rheumatology, Medicine, Clinical Neurology +7

High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis

Jéssica Castillo-Villalba, Sara Gil‐Perotín, Raquel Gasqué-Rubio et al. · Frontiers in Immunology · 2022 · 20 citations · Full text

Functional and structural changes in the visual pathway in multiple sclerosis

María Carcelén‐Gadea, Carlos Quintanilla‐Bordás, Alicia Gracia‐García et al. · Brain and Behavior · 2019 · 17 citations · Full text

The first reported case of drug‐induced hemolytic anemia caused by dimethyl fumarate in a patient with multiple sclerosis

Carlos Quintanilla‐Bordás, Emma Castro, María Carcelén‐Gadea et al. · Transfusion · 2019 · 15 citations

Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series

Carlos Quintanilla‐Bordás, Francisco Gascón, Carmen Alcalá et al. · Frontiers in Neurology · 2022 · 15 citations · Full text